BridgeMD
New treatment option for Frontotemporal Dementia
Official title STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
ClinicalTrials.gov ID: NCT06613204
What this study is testing
- What it's testing
- The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100. Healthy volunteers may be eligible.
You may be able to join if
- Family Care Partner
- Adult caring for family member with FTD.
- Provides 4 or more hours of care/week. Does not have to reside with.
- Identifies at least 2 moderately upsetting behaviors in the person with FTD.
- Speaks and understands English to be able to participate in intervention.
You likely can't join if
- Person with FTD
- No Frontotemporal Degeneration diagnosis.
- Unable to leave Care Partner during STELLA-FTD sessions.
- Enrolled in hospice. Exclusion Criteria: Family Care Partner
- Unable to find activity for Care Recipient during STELLA-FTD sessions to allow Care Partner to work privately with Guide and other Care Partners.
- Hearing and/or vision problems severe enough to prevent participation.
See the full eligibility criteria
- Family Care Partner
- Adult caring for family member with FTD.
- Provides 4 or more hours of care/week. Does not have to reside with.
- Identifies at least 2 moderately upsetting behaviors in the person with FTD.
- Speaks and understands English to be able to participate in intervention.
- Owns a telephone (smartphone, cell phone or landline).
- Has email and mailing address to receive computer, study materials and surveys.
- Provides informed consent to participate in the research.
- Lives in the US Person with FTD
- Diagnosis of FTD
- Family member of a Care Partner (this can be a relative, spouse, or close kin that is considered family).
- Lives in US
- Person with FTD
- No Frontotemporal Degeneration diagnosis.
- Unable to leave Care Partner during STELLA-FTD sessions.
- Enrolled in hospice. Exclusion Criteria: Family Care Partner
- Unable to find activity for Care Recipient during STELLA-FTD sessions to allow Care Partner to work privately with Guide and other Care Partners.
- Hearing and/or vision problems severe enough to prevent participation.
- Refuses to be video-recorded during STELLA-FTD sessions.
- Unwilling or unable to adequately follow study instructions and participate in study procedures.
The study team makes the final eligibility decision.
Where it's taking place
- Portland, Oregon, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Portland, Oregon, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.